Mark E. Diebel
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 3
- Oncology 3
- Cancer Cells and Metastasis 3
- Co-authors
- Emmanuelle Charafe‐Jauffret (3 shared papers)Gabriela Dontu (3 shared papers)Daniel Birnbaum (3 shared papers)Christophe Ginestier (3 shared papers)Max S. Wicha (3 shared papers)Julien Wicinski (2 shared papers)Giorgio Stassi (2 shared papers)François Bertucci (2 shared papers)
- Journals
- The Journal of Trauma: Injury, Infection, and Critical Care (6 papers)Cancer Research (1 paper)Clinical Cancer Research (1 paper)Critical Care Medicine (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Mark E. Diebel
12 papers receiving 2.4k citations
Mark E. Diebel's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.7k
- Cancer Research 601
- Biotechnology 128
- Molecular Biology 1.0k
- Immunology 293
Countries citing papers authored by Mark E. Diebel
This map shows the geographic impact of Mark E. Diebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Diebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Diebel more than expected).
Fields of papers citing papers by Mark E. Diebel
This network shows the impact of papers produced by Mark E. Diebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Diebel. The network helps show where Mark E. Diebel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Diebel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature Hit paper breakdown → | 2009 | 995 |
| 2 | CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Hit paper breakdown → | 2010 | 635 |
| 3 | Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer Hit paper breakdown → | 2009 | 617 |
| 4 | 2017 | 46 | |
| 5 | 2015 | 40 | |
| 6 | 2019 | 27 | |
| 7 | 2011 | 23 | |
| 8 | 2018 | 18 | |
| 9 | 2015 | 17 | |
| 10 | 2020 | 10 | |
| 11 | 2016 | 9 | |
| 12 | 2016 | 8 | |
| 13 | 2013 | 0 |
About Mark E. Diebel
Mark E. Diebel is a scholar working on Critical Care and Intensive Care Medicine, Oncology, Gastroenterology, Cancer Research and Immunology, having authored 13 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers), Immunotherapy and Immune Responses (1 paper), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), FOXO transcription factor regulation (1 paper) and 3D Printing in Biomedical Research (1 paper). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (601 citations), Biotechnology (128 citations), Molecular Biology (1.0k citations) and Immunology (293 citations). Mark E. Diebel has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Emmanuelle Charafe‐Jauffret, Gabriela Dontu, Daniel Birnbaum, Christophe Ginestier, Max S. Wicha, Julien Wicinski, Giorgio Stassi, François Bertucci, Patrice J. Viens and Flora Iovino. Their work appears in journals such as The Journal of Trauma: Injury, Infection, and Critical Care, Cancer Research, Clinical Cancer Research, Critical Care Medicine and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.